MetaCap

AngioDynamics Inc. (ANGO)

NASDAQ: ANGOHealth CareMedical/Dental InstrumentsUSD

10.81+0.05 (+0.46%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

ANGO stock chart

Technical analysis

Key statistics

All statistics
Market cap
$454.61M
EPS (TTM)
-$0.78
52-week range
9.39 – 16.29
Day range
10.53 – 10.99
Volume / Avg
430.34K / 651.16K
Beta
—

52-week range

$9.39$16.29

ANGO stock today

On Nov 20, ANGO ended the session at $10.81, adding $0.05 (0.46%), versus the S&P 500's 3.70% decline. Shares are 33.6% below their 52-week high of $16.29, set on Aug 19, 2026 and 15.1% above the 52-week low of $9.39, in the middle of the past year's range. ANGO is down 15.8% year to date, underperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has lost 9.5%.

AngioDynamics has posted a net loss over the last twelve months (EPS of -$0.78), so its P/E ratio is not meaningful.

Summary generated from market data by MetaCap's automated system. Methodology

About AngioDynamics

Company profile

AngioDynamics, Inc., a medical technology company, designs, manufactures, and sells products for the treatment of cardiovascular disease and cancer diagnoses in the United States and internationally. The company operates through Med Tech and Med Device segments. It offers Auryon Atherectomy system that delivers an optimized wavelength and short pulse width to remove lesions while preserving vessel wall endothelium.

Industry
Medical/Dental Instruments
CEO
Mr. Eric Honroth
Headquarters
Latham, NY
Employees
632
IPO year
2004

Financial highlights

Full financials

In fiscal 2026, AngioDynamics generated $320.2 million in revenue, up 9.5% from fiscal 2025. AngioDynamics reported a net loss of $36.7 million, compared with a loss of $34.0 million a year earlier. Gross margin was 54.6% (up from 53.9%) and operating margin -12.5%.

AngioDynamics annual revenue, net income and EPS
Fiscal yearFY 2026FY 2025FY 2024FY 2023FY 2022
Revenue$320.17M$292.50M$303.91M$338.75M$316.22M
Growth+9.46%-3.76%-10.28%+7.13%+8.66%
Net income$-36.74M$-33.99M$-184.35M$-52.44M$-26.55M
EPS (diluted)$-0.88$-0.83$-4.59$-1.33$-0.68

Analyst forecast

Forecast

Consensus (4 analysts)

none

Avg. price target

$19.75+82.70%

  • Strong buy 0
  • Buy 4
  • Hold 0
  • Sell 0
  • Strong sell 0

Target range

Low $17.00High $24.00

Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.

Earnings

Earnings history
Last reported (Aug/2026)
Oct 8, 2026
EPS actual vs est.
$-0.17 vs $-0.10
Surprise
-70.00%

ANGO news

All ANGO news

AngioDynamics peers

Health Care sector
ANGO peer companies
CompanyPrice% ChgMarket capCompare
MDXGMiMedx Group Inc3.05-1.93%$445.07Mvs ANGO
SENSSenseonics Holdings Inc.8.02-9.94%$439.34Mvs ANGO
CARLCarlsmed Inc.17.42+1.16%$477.38Mvs ANGO
SIShoulder Innovations Inc.20.15-0.79%$421.58Mvs ANGO
RCELAvita Medical Inc.15.62-2.31%$494.96Mvs ANGO
MOBIMobia Medical Inc.11.85-0.08%$394.50Mvs ANGO
CERSCerus Corporation1.85-2.63%$373.62Mvs ANGO
BWAYBrainsWay Ltd. ADR8.48-2.86%$341.35Mvs ANGO

Indexes, lists and sector

AngioDynamics stock FAQ

What is AngioDynamics's stock price today?

ANGO last traded at $10.81 as of Nov 20, 4:00 PM EST, up 0.46% on the day. Prices are delayed at least 15 minutes.

Who is AngioDynamics's CEO?

Mr. Eric Honroth is the chief executive officer of AngioDynamics Inc., which has about 632 employees.

What is the ANGO 52-week high?

The 52-week high for ANGO is $16.29 and the 52-week low is $9.39. The stock is currently 33.6% below its high.

Compare ANGO